PARADIGM BIOPHARMACEUTICALS LIMITED
PARADIGM BIOPHARMACEUTICALS LIMITED is a Public Limited Company registered in Australia under 94169346963, and its current status with Australian Securities and Investments Commission (ASIC) is active. The company was incorporated on 2 May 2014 and lists its registered address as Australia. 5 shareholders are on record for PARADIGM BIOPHARMACEUTICALS LIMITED, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Australian Securities and Investments Commission (ASIC) and was last updated on 1 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for PARADIGM BIOPHARMACEUTICALS LIMITED, held on the share register, filed under section 168 of the Corporations Act 2001.
The largest of these is Vanguard International Stock Index-Total Intl Stock Indx, holding 42.4% — the largest recorded stake — followed by Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund at 24.5%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 13 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 42.4% | Australian Securities and Investments Commission (ASIC) | |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 24.5% | Australian Securities and Investments Commission (ASIC) | |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 12.9% | Australian Securities and Investments Commission (ASIC) | |
| Schwab Strategic Tr-Schwab International Small Cap Equity ETF | 6.4% | Australian Securities and Investments Commission (ASIC) | |
| Vanguard International Stock Index-Pacific Stock Index | 4.8% | Australian Securities and Investments Commission (ASIC) |
Officers
5
The Director Of Investor Relations of PARADIGM BIOPHARMACEUTICALS LIMITED currently on record is Simon White; five officers are currently on record for PARADIGM BIOPHARMACEUTICALS LIMITED, filed with Australian Securities and Investments Commission (ASIC).
The register reports 9 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at PARADIGM BIOPHARMACEUTICALS LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
PARADIGM BIOPHARMACEUTICALS LIMITED has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 3 subsidiaries span Australia, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 3 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
PARADIGM BIOPHARMACEUTICALS LIMITED
Australia
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns PARADIGM BIOPHARMACEUTICALS LIMITED?
Five shareholders are currently on record for PARADIGM BIOPHARMACEUTICALS LIMITED, held on the share register, filed under section 168 of the Corporations Act 2001. The largest of these is Vanguard International Stock Index-Total Intl Stock Indx, holding 42.4% — the largest recorded stake — followed by Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund at 24.5%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is PARADIGM BIOPHARMACEUTICALS LIMITED's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for PARADIGM BIOPHARMACEUTICALS LIMITED is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does PARADIGM BIOPHARMACEUTICALS LIMITED have on record?
5 shareholders are shown on record for PARADIGM BIOPHARMACEUTICALS LIMITED. The register reports 13 in total; only the top 5 by holding are shown here.
What is PARADIGM BIOPHARMACEUTICALS LIMITED's company registration number?
PARADIGM BIOPHARMACEUTICALS LIMITED's registration number is 94169346963, filed with Australian Securities and Investments Commission (ASIC) in Australia. Its current status on the register is active.
Is PARADIGM BIOPHARMACEUTICALS LIMITED still an active company?
PARADIGM BIOPHARMACEUTICALS LIMITED's status on Australian Securities and Investments Commission (ASIC) is listed as active.
When was PARADIGM BIOPHARMACEUTICALS LIMITED incorporated?
PARADIGM BIOPHARMACEUTICALS LIMITED was incorporated on 2 May 2014, according to Australian Securities and Investments Commission (ASIC).
What is PARADIGM BIOPHARMACEUTICALS LIMITED's registered address?
The registered address on file for PARADIGM BIOPHARMACEUTICALS LIMITED is Australia.
What legal structure is PARADIGM BIOPHARMACEUTICALS LIMITED registered as?
PARADIGM BIOPHARMACEUTICALS LIMITED is registered as a Public Limited Company in Australia.
Who are the officers/directors of PARADIGM BIOPHARMACEUTICALS LIMITED?
The Director Of Investor Relations of PARADIGM BIOPHARMACEUTICALS LIMITED currently on record is Simon White; five officers are currently on record for PARADIGM BIOPHARMACEUTICALS LIMITED, filed with Australian Securities and Investments Commission (ASIC). Management authority at PARADIGM BIOPHARMACEUTICALS LIMITED sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does PARADIGM BIOPHARMACEUTICALS LIMITED have a parent company or subsidiaries?
PARADIGM BIOPHARMACEUTICALS LIMITED has no recorded parent company — it sits at the top of its own group structure, with 3 subsidiaries recorded beneath it across 2 jurisdictions. Those 3 subsidiaries span Australia, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 3 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to PARADIGM BIOPHARMACEUTICALS LIMITED's ownership over time?
This profile reflects a point-in-time snapshot from Australian Securities and Investments Commission (ASIC). Zavia's monitoring API can track changes to PARADIGM BIOPHARMACEUTICALS LIMITED's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access PARADIGM BIOPHARMACEUTICALS LIMITED's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Australia, so records like PARADIGM BIOPHARMACEUTICALS LIMITED's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Australian Securities and Investments Commission (ASIC) and was last synced on 1 October 2026.